Tuberc Respir Dis > Volume 36(3); 1989 > Article
Tuberculosis and Respiratory Diseases 1989;36(3):233-237.
DOI: https://doi.org/10.4046/trd.1989.36.3.233    Published online September 1, 1989.
Site of Bronchodilatation with Inhaled Fenoterol and Ipratropium Bromide in Bronchial Asthma
Chun Soo Oh, In Seon Choi, Chang Hoon Song, Young Chul Kim, Jung Il Kim, Jae Beom Yang, Kyung Ok Park
Department of Internal Medicine, Chonnam University Medical School, Chonnam, Korea
기관지천식에 있어서 흡입성 Fenoterol과 Ipratropium Bromide에 의한 기도확장부위에 관한 연구
오춘수, 최인선, 송창훈, 김영철, 김정일, 양재범, 박경옥
Abstract
To assess site of action of bronchodilatation with a beta adrenergic agonist, fenoterol, and an anticholinergic bronchodilator, ipratropium bromide, we measured the density dependence of maximal expiratory flow rate in 37 asthmatics There were no significant changes in Δ V max 50 with either agent. However, there were significant inverse correlations between the prebronchodilator Δ V max 50 and the change in ΔV max 50 after the administration of fenoterol or ipratropium. These results suggest that sites of bronchodilatation in asthmatics are not different between fenoterol and ipratropium, and those are related to the prebronchodilator site of obstruction.
TOOLS
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 1,206 View
  • 12 Download
Related articles


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next